Cargando…

Response of Depression to Botulinum Toxin Treatment: Agitation as a Predictor

Detalles Bibliográficos
Autor principal:	Milev, Roumen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2015
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4403301/ https://www.ncbi.nlm.nih.gov/pubmed/25941497 http://dx.doi.org/10.3389/fpsyt.2015.00055

Ejemplares similares

Agitation Predicts Response of Depression to Botulinum Toxin Treatment in a Randomized Controlled Trial
por: Wollmer, M. Axel, et al.
Publicado: (2014)

Olfactory Functioning and Depression: A Systematic Review
por: Taalman, Hannah, et al.
Publicado: (2017)

The Efficacy, Safety, and Tolerability of Probiotics on Depression: Clinical Results From an Open-Label Pilot Study
por: Wallace, Caroline J. K., et al.
Publicado: (2021)

Effects of Electroconvulsive Therapy and Repetitive Transcranial Magnetic Stimulation on Serum Brain-Derived Neurotrophic Factor Levels in Patients with Depression
por: Gedge, Laura, et al.
Publicado: (2012)

Treatment of Depression with Botulinum Toxin
por: Wollmer, Marc Axel, et al.
Publicado: (2022)

Efficacy and Safety of Botulinum Toxin vs. Placebo in Depression: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Qian, Huan, et al.
Publicado: (2020)

Psychomotor Agitation Non-responsive to Treatment: A Case Report of Phenibut Withdrawal Syndrome
por: Esposito, Cecilia Maria, et al.
Publicado: (2021)

Insulin Resistance as a Shared Pathogenic Mechanism Between Depression and Type 2 Diabetes
por: Lyra e Silva, Natalia de M., et al.
Publicado: (2019)

Treatment of Agitation With Lorazepam in Clinical Practice: A Systematic Review
por: Amore, Mario, et al.
Publicado: (2021)

Interactive Effects of Agitation and Cognitive Impairment on Odor Identification in Patients With Late-Life Depression
por: Zhang, Si, et al.
Publicado: (2022)

1st International Experts’ Meeting on Agitation: Conclusions Regarding the Current and Ideal Management Paradigm of Agitation
por: Martínez-Raga, José, et al.
Publicado: (2018)

Botulinum Neurotoxin Therapy for Depression: Therapeutic Mechanisms and Future Perspective
por: Li, Yang, et al.
Publicado: (2021)

COVID-19 Pandemic: The Impact of COVID-19 on Mental Health and Life Habits in the Canadian Population
por: Iftene, Felicia, et al.
Publicado: (2022)

The safety and efficacy of botulinum toxin A on the treatment of depression
por: Zhang, Qilin, et al.
Publicado: (2021)

Using electronically delivered therapy and brain imaging to understand OCD pathology: A pilot feasibility study
por: Stephenson, Callum, et al.
Publicado: (2023)

Botulinum Toxin Treatment for Depression: A New Paradigm for Psychiatry
por: Finzi, Eric
Publicado: (2023)

Rasch analyses of the Quick Inventory of Depressive Symptomatology Self-Report in neurodegenerative and major depressive disorders
por: Vaccarino, Anthony L., et al.
Publicado: (2023)

Issues in the Management of Acute Agitation: How Much Current Guidelines Consider Safety?
por: Pacciardi, Bruno, et al.
Publicado: (2013)

Botulinum Toxin in the Treatment of Headache
por: Becker, Werner J.
Publicado: (2020)

Wrist accelerometry for monitoring dementia agitation behaviour in clinical settings: A scoping review
por: Cheung, James Chung-Wai, et al.
Publicado: (2022)

Police Encounters, Agitation, Diagnosis, and Employment Predict Psychiatric Hospitalisation of Intensive Home Treatment Patients During a Psychiatric Crisis
por: Barakat, Ansam, et al.
Publicado: (2021)

A Systematic Review of Cognitive Predictors of Treatment Outcome in Major Depression
por: Groves, Samantha J., et al.
Publicado: (2018)

BOTULINUM TOXIN
por: Nigam, P K, et al.
Publicado: (2010)

Predictors of Treatment Response to an Internet-Delivered Intervention Targeting Residual Cognitive Symptoms After Major Depressive Disorder
por: Myklebost, Sunniva Brurok, et al.
Publicado: (2022)

Pharmacological prevention of postictal agitation after electroconvulsive therapy—A systematic review and meta-analysis
por: Feenstra, Thomas C., et al.
Publicado: (2023)

Predictors of Response to Intradetrusor Botulinum Toxin-A Injections in Patients with Idiopathic Overactive Bladder
por: Cohen, Brian L., et al.
Publicado: (2009)

Injecting botulinum toxin into the treatment of blepharospasm
por: Popescu, Marius Nicolae, et al.
Publicado: (2018)

Botulinum Toxin for the Treatment of Hand Tremor
por: Niemann, Nicki, et al.
Publicado: (2018)

Botulinum Toxin for the Treatment of Neuropathic Pain
por: Park, JungHyun, et al.
Publicado: (2017)

Botulinum toxin for treatment of restrictive strabismus()
por: Merino, Pilar S., et al.
Publicado: (2017)

Immunogenicity Associated with Botulinum Toxin Treatment
por: Bellows, Steven, et al.
Publicado: (2019)

Causes of Botulinum Toxin Treatment Failure
por: Shtefan, Valentina, et al.
Publicado: (2022)

Can a personalised music listening intervention decrease agitation in hospitalised patients with dementia? A feasibility trial
por: Lee, Shanna, et al.
Publicado: (2023)

The effects of probiotics on depressive symptoms in humans: a systematic review
por: Wallace, Caroline J. K., et al.
Publicado: (2017)

O059. Predictors of response to botulinum toxin for the treatment of chronic migraine: data from a Headache Center
por: Ornello, Raffaele, et al.
Publicado: (2015)

Erratum to: The effects of probiotics on depressive symptoms in humans: a systematic review
por: Wallace, Caroline J. K., et al.
Publicado: (2017)

Commentary: Parental Depressive Symptoms as a Predictor of Outcome in the Treatment of Child Internalizing and Externalizing Problems
por: Tahir, Talha, et al.
Publicado: (2019)

Baseline depressive symptoms as predictors of efficacy and tolerability of the treatment with duloxetine: a network analysis approach
por: Maciaszek, Julian, et al.
Publicado: (2023)

Which Emergent Medication Should I Give Next? Repeated Use of Emergent Medications to Treat Acute Agitation
por: Searles Quick, Veronica B., et al.
Publicado: (2021)

Headache and botulinum toxin
por: Porta, M., et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_9ojbabj7c809ibhgl4lqhvc8fv